BIRC3 antibody (AA 101-131)
Quick Overview for BIRC3 antibody (AA 101-131) (ABIN3030108)
Target
See all BIRC3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 101-131
-
Purpose
- cIAP2 Antibody
-
Purification
- Antigen affinity
-
Immunogen
- A portion of amino acids 101-131 from the human protein was used as the immunogen for this cIAP2 antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Titration of the cIAP2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the cIAP2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- BIRC3 (Baculoviral IAP Repeat Containing 3 (BIRC3))
-
Alternative Name
- cIAP2
-
Background
- BIRC3 is a member of a family of proteins that inhibits apoptosis by binding to tumor necrosis factor receptor-associated factors TRAF1 and TRAF2, probably by interfering with activation of ICE-like proteases. The encoded protein inhibits apoptosis induced by serum deprivation but does not affect apoptosis resulting from exposure to menadione, a potent inducer of free radicals. The amino acid sequence predicts three baculovirus IAP repeat domains and a ring finger domain.
-
UniProt
- Q13489
-
Pathways
- Apoptosis, Caspase Cascade in Apoptosis, Activation of Innate immune Response, Toll-Like Receptors Cascades
Target
-